Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.
Luiz Filipe Gonçalves de Oliveira,Armando de Oliveira Schubach,Maria de Fátima Moreira Martins,Sonia Regina Lambert Passos,Raquel de Vasconcellos Carvalhaes de Oliveira,Mauro Célio de Almeida Marzochi,Carlos Augusto Ferreira de Andrade +6 more
Reads0
Chats0
TLDR
Although closer surveillance is needed for the treatment of cutaneous leishmaniasis, antileishmanial drugs are basically safe and severe side effects requiring the discontinuation of treatment are relatively uncommon.About:
This article is published in Acta Tropica.The article was published on 2011-05-01 and is currently open access. It has received 306 citations till now. The article focuses on the topics: Adverse effect & Leishmaniasis.read more
Citations
More filters
Journal ArticleDOI
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
Naomi E. Aronson,Barbara L. Herwaldt,Michael Libman,Richard D. Pearson,Rogelio López-Vélez,Peter J. Weina,Edgar M. Carvalho,Moshe Ephros,Selma M. B. Jeronimo,Alan J. Magill +9 more
TL;DR: It is important to realize that leishmaniasis guidelines cannot always account for individual variation among patients, and that adherence to these guidelines to be voluntary.
Journal ArticleDOI
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)*
Naomi E. Aronson,Barbara L. Herwaldt,Michael Libman,Richard D. Pearson,Rogelio López-Vélez,Peter J. Weina,Edgar M. Carvalho,Moshe Ephros,Selma M. B. Jeronimo,Alan J. Magill +9 more
TL;DR: This research presents a novel and scalable approach called “informed consent” that allows for real-time decision-making in the management of infectious disease outbreaks in the rapidly changing environment.
Journal ArticleDOI
Cutaneous and mucocutaneous leishmaniasis : Differential diagnosis, diagnosis, histopathology, and management
TL;DR: The diagnosis of leishmaniasis can be challenging because it mimics both infectious and malignant conditions as discussed by the authors, and a misdiagnosis may lead to an unfavorable outcome, and appropriate management requires an accurate diagnosis, which often includes identification of the specific etiologic species.
Journal ArticleDOI
Chemical composition of Mentha pulegium and Rosmarinus officinalis essential oils and their antileishmanial, antibacterial and antioxidant activities
Abdelhakim Bouyahya,Abdelhakim Bouyahya,Abdeslam Et-Touys,Youssef Bakri,Ahmed Talbaui,Hajiba Fellah,Jamal Abrini,Nadia Dakka +7 more
TL;DR: Findings show that the EOs of M. pulegium and R. officinalis are good sources of bioactive molecules that could have potential applications in the food and pharmaceutical industries.
Oportunidades para inovação no tratamento da leishmaniose usando o potencial das plantas e produtos naturais como fontes de novos fármacos Potential for innovation in the treatment of leishmaniasis using plants and natural products as sources of new drugs
TL;DR: The main drug used in Brazil, Glucantime®, presents several adverse effects and represents high cost to the country as discussed by the authors, and the drugs of choice for all clinical forms of leishmaniasis are still pentavalent antimonials.
References
More filters
Journal ArticleDOI
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati,Douglas G. Altman,Jennifer Tetzlaff,Cynthia D. Mulrow,Peter C Gøtzsche,John P. A. Ioannidis,Mike Clarke,Mike Clarke,Philip J. Devereaux,Jos Kleijnen,David Moher +10 more
TL;DR: An Explanation and Elaboration of the PRISMA Statement is presented and updated guidelines for the reporting of systematic reviews and meta-analyses are presented.
Book
Cochrane Handbook for Systematic Reviews of Interventions
Julian P T Higgins,Sally Green +1 more
TL;DR: The Cochrane Handbook for Systematic Reviews of Interventions is the official document that describes in detail the process of preparing and maintaining Cochrane systematic reviews on the effects of healthcare interventions.
Journal ArticleDOI
Goodman and Gilman's the Pharmacological Basis of Therapeutics
William H. Stigelman,Pharm D. +1 more
Journal ArticleDOI
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPRISMA: Explanation and Elaboration
Alessandro Liberati,Douglas G. Altman,Jennifer Tetzlaff,Cynthia D. Mulrow,Peter C Gøtzsche,John P. A. Ioannidis,Mike Clarke,Philip J. Devereaux,Jos Kleijnen,David Moher +9 more
TL;DR: The updating of the QUOROM Statement is described, to ensure clear presentation of what was planned, done, and found in a systematic review, and the name of the reporting guidance was changed to PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses).
Book ChapterDOI
International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use
TL;DR: The official goal of the ICH is to harmonize inconsistent technical regulatory standards across different regions and countries in order to avoid costly, wasteful, and duplicative testing in pharmaceutical development.